V1RC2 inhibitors represent a class of chemical compounds characterized by their specific interactions with the V1RC2 protein, defined by a variety of chemical structures and functional groups that facilitate their binding and inhibition. These compounds are typically synthesized through the incorporation of diverse functional groups, including heterocyclic rings, aromatic systems, and various substituents that enhance their binding affinity and selectivity. The core structures of V1RC2 inhibitors often feature a blend of hydrophobic and hydrophilic regions, which are meticulously designed to interact with the target protein's active or allosteric sites. The specificity of these interactions is governed by the precise arrangement of functional groups, which allows the inhibitors to form stable complexes with the protein.
The design and optimization of V1RC2 inhibitors involve sophisticated chemical and computational strategies. Synthesis begins with the construction of complex molecules through various organic reactions, followed by structural modifications to improve efficacy. Computational tools such as molecular docking and molecular dynamics simulations play a crucial role in predicting the binding modes of these inhibitors and guiding structural adjustments. Iterative cycles of synthesis and testing refine the chemical properties and binding interactions of the inhibitors. The development process emphasizes the importance of understanding the three-dimensional structure of the V1RC2 protein and the nature of its interaction with potential inhibitors, leading to the creation of compounds with high specificity and potency.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Acts as a phytoalexin, modulating cellular signaling pathways, potentially inhibiting Vomeronasal 1 receptor 29 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Exhibits anti-inflammatory properties, interfering with molecular pathways involved in Vomeronasal 1 receptor 29 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A potent antioxidant, EGCG may disrupt pathways involved in Vomeronasal 1 receptor 29 expression, potentially inhibiting it. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Known for its anti-inflammatory effects, quercetin could interfere with the signaling cascades associated with Vomeronasal 1 receptor 29 expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Acts as a tyrosine kinase inhibitor, potentially disrupting cellular pathways involved in Vomeronasal 1 receptor 29 expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
A natural compound with anti-inflammatory properties, sulforaphane may modulate cellular pathways related to Vomeronasal 1 receptor 29 expression. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Exhibits anti-inflammatory effects and may interfere with signaling pathways associated with Vomeronasal 1 receptor 29 expression. | ||||||
Baicalein | 491-67-8 | sc-200494 sc-200494A sc-200494B sc-200494C | 10 mg 100 mg 500 mg 1 g | $32.00 $42.00 $162.00 $292.00 | 12 | |
Has been shown to modulate inflammatory responses, potentially impacting the expression of Vomeronasal 1 receptor 29. | ||||||
Gingerol | 23513-14-6 | sc-201519 sc-201519A | 5 mg 20 mg | $109.00 $387.00 | 5 | |
Exhibits anti-inflammatory properties and may interfere with cellular pathways involved in Vomeronasal 1 receptor 29 expression. | ||||||
Diosgenin | 512-04-9 | sc-205652 sc-205652B sc-205652A | 5 g 25 g 100 g | $47.00 $131.00 $517.00 | 4 | |
Displays anti-inflammatory effects, potentially interfering with molecular pathways implicated in Vomeronasal 1 receptor 29 expression. | ||||||